Zydus group has launched SoviHep, which will provide succour to more than 10 million patients who suffer from Hepatitis C in India. The therapy will be MARKETED by the speciality division of the group, Zydus Heptiza. Zydus and Gilead Sciences had signed a non-exclusive licensing agreement which will allow the manufacture of sofosbuvir and the fixed-dose combination of ledipasvir/ sofosbuvir for distribution in 91 countries including India. Description Indian Brand Name: SOVIHEP , Generic Name:SOFOSBUVIR Manufacturer:Zydus Cadila Strength:400mg Packaging:Bottle of 28 Tablets Warning: The above information is an educational aid only. It is not intended as medical advice for individual conditions or treatments. Talk to your doctor, nurse or pharmacist before following any medical regimen to see if it is safe and effective for you. Note: Sovihep is a prescription Drug and should be used under Proper Medical Guidance and Advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.